The short interest data are out for the most recent settlement date, December 30. Generally speaking, companies within the biotech industry are considered to have a riskier group of stocks, with big potential upside and big potential downside. As we have approached Trump’s inauguration, the health care sector in general has rallied. Now it’s time to see what the bears have to say about this rally.
As we have said before, FDA rulings can make or break the biotech stocks, and short sellers and mega-bulls often go to war against each other in these companies. After all, if a single failed clinical trial can mean disaster for a stock, then some short sellers can argue for a stock implosion down the road.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The December 30 short interest data have been compared with the previous report, and short interest was down in most of the selected stocks.
Amgen Inc. (NASDAQ: AMGN) saw its short interest decrease to 6.22 million shares from the previous level of 6.90 million. Shares were last seen trading at $156.62, in a 52-week trading range of $133.64 to $176.85.
Biogen Inc. (NASDAQ: BIIB) had its short interest increase to 2.07 million shares from the previous 1.99 million. The stock was recently trading at $287.11, within a 52-week range of $223.02 to $333.65.
Celgene Corp.’s (NASDAQ: CELG) short interest for this settlement date decreased to 7.67 million shares from the previous 7.71 million. Shares were changing hands at $117.24, in a 52-week range of $93.05 to $127.00.
Gilead Sciences Inc. (NASDAQ: GILD) saw its short interest decrease to 13.37 million shares from 14.98 million in the previous period. Shares were trading at $73.77, in a 52-week trading range of $70.83 to $103.10.
MannKind Corp. (NASDAQ: MNKD) saw the number of its shares short decrease to 98.60 million. The previous reading was 106.22 million. The stock was last seen at $0.63, in a 52-week range of $0.41 to $2.24. Note that MannKind is one of the most shorted Nasdaq stocks.
Alexion Pharmaceuticals Inc.’s (NASDAQ: ALXN) short interest increased to 5.55 million, compared to the previous level of 5.50 million. Shares were recently trading at $136.66, in a 52-week range of $109.12 to $169.84.
It’s Your Money, Your Future—Own It (sponsor)
Retirement can be daunting, but it doesn’t need to be.
Imagine having an expert in your corner to help you with your financial goals. Someone to help you determine if you’re ahead, behind, or right on track. With SmartAsset, that’s not just a dream—it’s reality. This free tool connects you with pre-screened financial advisors who work in your best interests. It’s quick, it’s easy, so take the leap today and start planning smarter!
Don’t waste another minute; get started right here and help your retirement dreams become a retirement reality.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.